RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company, will release its fourth-quarter and full-year 2024 financial results on Wednesday, February 12, 2025, before the market opens.
The company will host a conference call at 8:30 a.m. ET to discuss the results. Domestic participants can dial 1-800-717-1738 to join, while international callers can use 1-646-307-1865. Additionally, a live webcast of the event will be accessible through the Investor Relations section of Mineralys’ website.
The upcoming financial results will provide insights into Mineralys’ progress in developing treatments for hypertension, chronic kidney disease, obstructive sleep apnea, and other conditions linked to dysregulated aldosterone. These findings will be pivotal as the company advances its clinical-stage programs and evaluates the next steps in its research and development pipeline.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.